Cardiovascular imaging to quantify the evolution of cardiac diseases in clinical development

Author： Klein Gregory   Thirion Jean-Philippe  

Publisher： Informa Healthcare

ISSN： 1366-5804

Source： Biomarkers, Vol.10, Iss.1, 2005-11, pp. : 1-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vivo Optical Molecular Imaging of Cardiovascular Diseases: Long Road Ahead

By  

Current Molecular Imaging, Vol. 3, Iss. 2, 2014-07 ,pp. : 118-128

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular diseases in China

By Liu Lisheng  

Biochemistry and Cell Biology, Vol. 85, Iss. 2, 2007-04 ,pp. : 157-163

NRC Research Press

Access to resources Recommend Favorite

Role of reactive aldehyde in cardiovascular diseases

By Uchida K.  

Free Radical Biology and Medicine, Vol. 28, Iss. 12, 2000-06 ,pp. : 1685-1696

Elsevier

Access to resources Recommend Favorite

Chaperones and Cardiac Misfolding Protein Diseases

By  

Current Protein and Peptide Science, Vol. 15, Iss. 3, 2014-05 ,pp. : 189-204

Bentham Science Publishers

Access to resources Recommend Favorite

Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases: a review

By Sumer E. U.   Schaller S.   Sondergaard B. C.   Tankó L. B.   Qvist P.  

Biomarkers, Vol. 11, Iss. 6, 2006-11 ,pp. : 485-506

Informa Healthcare

Access to resources Recommend Favorite